GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
We need to keep expectations of the IND app submission realistic. The app has to be entirely complete before it can be sent. We dont have all the staff recruited for the manufacturing lab yet as you've pointed out. Manufacturing is an integral part of the IND app as HEMO are producing the cells themselves in-house. All test runs on production of the drug have to prove they can produce the cells cleanly.
Market sentiment needs to change from bears to bulls at some point.
Investors appetite for risk is on the floor. Most junior pharmas taking the sting over the last 12 months
DDDD, TILS, N4P, AVACTA (in the midst of a recovery) etc
HEMO has the goods and is going well. Just needs time as always. We want them to produce a $1b+ drug or process then we need them to do it properly!!
Focus your energy on a hobby maybe. Fishing? Cricket?
Log back in once a month. Sit back and relax. Analysing every trade is pointless as everyone continues to point out. You should be invested for the target projects at HEMO, which all take time. You know where they are up to. Stop going on about pointless stuff and chill out.
People will sell whenever they want
This is a still a fearful and defensive market
Cash is King for many. Personal circumstances often demand sales! Maybe they even made a profit from the other week?
Who knows. I really don’t care. Good luck to all.
Agreed Tillywhiz
It wont be a linear rise to 50p plus on developing a working drug or platform. But it has to start moving up at some point!
Hope investors keep the faith and can hold long enough to see HEMO blossom.
Agree it cant be £15m market cap for too much longer.
I think investors personal timelines heavily effect their views on HEMOs perceived success. Those accumulating stock at these prices and putting away for a few years will be the ones laughing.
Those wanting quick progress have been left frustrated sadly. But it is pharma after all. I dont imagine discovering cancer ending drugs is an easy process.
The current SP doesn't make it a bad investment even if you bought at 10p. That is, providing you are holding for 3-5 years. They'll be a bit anyed they have missed the cheap shares but not arguing on forums daily. Those who need their capital back in the short term are under pressure. That is not Vlad's fault.
I am WAY down from initial investments from way back when. However, I keep trying to accumulate more cheap ones as each month passes by. My son's JISA can wait as long as it takes for HEMO to succeed, he's only 4 haha
As Vlad said, its billions and years after all.
I think this needs another bump for good measure.
No one who has invested £70k comes on here moaning to the ends of the earth about the company and pontification whether to sell 300 times over months and months. Making statements to which no one what responses he wants or expects to get. Its pure negative spamming.
He's a trader who witters when hes out and refers to his 'clever friend' when he is in. I dont dislike anyone trying to make money trading HEMO. What I don't like is frauds peddling BS to further their agenda.
This guy is NOT a genuine investor. Never regard his posts as anything other that him being 'in' or 'out' depending on the negative and positive twist to his posts. (not so much positive with the current SP)
Genuine holders, things are getting better every month. This stock gets more and more undervalued as each week passes and the company close on trials of SAFE HEMO CAR T.
Some support at this stage seems pointless to me. It is all dependent upon the progress of the science.
We are still pre clinical as I said. Nothing has changed for a long while. The action begins when we go clinical. Then new doors start to open and Vlad will need help explore them all!
So everyone would be happy to spend vital resource for trials on additional Senior Management positions? In the past HEMO has never had the funds.
Now, you could say they have.
So what should be the CEOs priority at this point in its evolution? Marketing, a COO a hands on MD? None of these people would effect the progress of the science, the integral part of HEMO's potential. But I bet they would be demanding sizeable salaries. Trials are imminent (in pharma terms ;-) and I believe the shouted for PR will arrive at that point. We have been pre clinical for so long there is nothing new to tell the market. That will change when FDA give us the nod ;-)
IMO I'd suggest Vlad's priorities should be:
1. Making the remaining cash last as long as possible with HEMO CAR T phase 1/2a trials in mind. This is the golden goose right now. Cash keeps the wheels turning.
2. Do whatever it takes to get our IND app to get the green light for trials via FDA. I am sure we are already all over this.
3. Have a planned strategy to secure non-dilutive funding when those options become available in our trajectory. (I understand we are on this as well)
4. Impress and wow the potential suitors in the ongoing CBR platform talks with other pharma with whom we wish to partner up and secure ongoing funding of that project via that route. "Talking to governments"?! Sounds very exciting. You'd think there wouldn't be a government clambering for some sort of 'defence' against future viruses after COVID 19.
5. CDX can come right back into focus once HEMO CAR T hits trials. In my view Vlad will be looking to partner up with CDX too for different specific diseases that CDX can treat with different partners (Hopefully!!!). We certainly wont be raising to take CDX forward at this SP as they simply wont get what they need. The SP has to be a great deal higher for that sort of raise.
Anyhow, HEMO remains a pearl of an investment. Some peripheral stuff continues to P!55 me off (the last interview was very poor imo) but the fundamental scientific pre clinical breakthroughs are novel and 100% required by the human race. The world needs HEMO CAR T, a CBR platform for disease X and CDX Monoclonal antibodies to support the medical profession save more peoples lives.
And for clarity when I say 3-5 years Im talking from when I first invested over two years ago. So we are well into this time horizon as I see it.
The investment profile for HEMO is in as strong a position as it has ever been. I trust the SP will catch, I continue to keep the faith.
Social media is full of traders. Their numbers are massively down from last year! But mainly the Covid cash bubble of amateur investors is long gone. Twitter was for them. Now everyone is back to work whether they are investing still or not.
Thankfully Social Media makes zero difference the success of HEMO. But yes, its quiet. Don't go on there, its much easier not reading it!
A poor interview with lots of "hope so's". Doest really change the investment profile of HEMO for me.
There seems to be zero appetite for the risks associated with pre-clinical junior pharmas. It's a good thing were are moving clinical soon finally!
I have total faith HEMO will produce one or more drugs/platforms that work and the SP will reflect this at some point in the future, even this year once HEMO CAR T gets the nod from FDA to go to hum trials.
It's all about timescales. Bio tech 3-5 years. HEMO is an excellent investment right now for a hold through trials.
Unfortunately many of us have a lot higher average so can see why people are fuming. Biotechs and the small caps will have their times return again. Hopefully a market bull run times with our CAR T trial action.